Novo Nordisk's $199 Ozempic Deal Shows What Telehealth Platforms Can Do for Pharma
2 Articles
2 Articles
Novo Nordisk's $199 Ozempic deal shows what telehealth platforms can do for pharma
On Monday, Novo Nordisk announced a discount on its popular drugs for diabetes and obesity, Ozempic and Wegovy, cutting prices for the lowest doses to $199 when patients pay cash through Novo’s pharmacy NovoCare. Patients searching for those deals online, though, won’t always get funneled to the drugmaker’s sites. Instead, the first results they may see are ads from telehealth companies that partner with Novo Nordisk. Sponsored Google search r…
Novo Nordisk Reduces Prices for GLP-1 Medications Amid Rising Demand for Diabetes and Weight Loss Treatments
Novo Nordisk has announced significant price reductions […] The post Novo Nordisk Reduces Prices for GLP-1 Medications Amid Rising Demand for Diabetes and Weight Loss Treatments first appeared on GeneOnline News. The post Novo Nordisk Reduces Prices for GLP-1 Medications Amid Rising Demand for Diabetes and Weight Loss Treatments appeared first on GeneOnline News.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
